Toshihiro Nanki - Publications

JCS 2026 Guideline on Management of Large Vessel Vasculitis.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 22, 2026

Efficacy of romosozumab as sequential therapy for bisphosphonates in glucocorticoid-induced osteoporosis.

Journal: JBMR plus

Published: March 08, 2026

Differences in chest HRCT findings in relation to ANCA subtypes in ANCA-associated vasculitis.

Journal: Respiratory investigation

Published: February 17, 2026

Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: January 27, 2026

Epidemiology and clinical characteristics of polyarteritis nodosa in Japan: findings from a nationwide survey.

Journal: Seminars in arthritis and rheumatism

Published: January 23, 2026

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Journal: Annals of the rheumatic diseases

Published: October 27, 2025

Anti-SRP antibody-positive polymyositis complicated by neuromyelitis optica spectrum disorder: a case report and literature review.

Journal: Modern rheumatology case reports

Published: September 29, 2025

Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis reduced glucocorticoid dose and improved residual symptoms compared to conventional immunosuppressants: a retrospective observational study.

Journal: Rheumatology international

Published: July 18, 2025

Long-Term Effectiveness and Safety of Denosumab for Osteoporosis in Patients With Rheumatic Diseases.

Journal: The Journal of rheumatology

Published: May 20, 2025

Evaluation of anti-drug antibodies against therapeutic monoclonal antibodies and related product in Japanese patients with rheumatoid arthritis and their clinical impact.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: April 22, 2025

Effectiveness of Daily Teriparatide in Managing Glucocorticoid-Induced Osteoporosis in Rheumatic Disease Patients After Switching From Bisphosphonate Therapy.

Journal: Cureus

Published: April 17, 2025

Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan.

Journal: Clinical rheumatology

Published: September 27, 2024